Rosenstock J, Balas B, Charbonnel B, Bolli GB, Boldrin M, Ratner R, et al
The standard treatment for HFpEF includes sodium-glucose cotransporter 2 inhibitors (SGLT2i), such as empagliflozin and dapagliflozin, supported by the EMPEROR-Preserved (2021) and DELIVER (2022) trials [7, 8]
doi:10.1210/me.2005-0187 330
40,64 Many of the mechanisms by which neurotransmitters regulate insulin secretion remain unclear and this area requires further investigation
But maybe this is improving insulin sensitivity, improving the blood flow to the hair, reducing fibrosis and reducing inflammation, and ultimately, because of helping the insulin sensitivity, reducing the hyperandrogenic states. She also notes that different GLP-1 receptor agonists may have varying effects on hair loss, and that dosing differs between treatment for type 2 diabetes and weight loss
A GLP-1 user eats less at a sitting